Avacta signs distribution agreement with ABCAM for Covid-19 Affimer reagents
Cancer therapies and diagnostics group Avacta entered into a global distribution agreement with ABCAM to sell the company'sSARS-CoV-2 research Affimer reagents.
Under the worldwide, non-exclusive...
Tue, 06/04/2021 - 09:26